Your browser doesn't support javascript.
loading
Relationship between hepatitis C infection and treatment status and COVID-19-related hospitalizations in Georgia.
Aslanikashvili, Ana; Rylander, Charlotta; Manjavidze, Tinatin; Gamkrelidze, Amiran; Baliashvili, Davit; Anda, Erik Eik.
  • Aslanikashvili A; Department of Community Medicine, University of Tromsø - The Arctic University of Norway, 9037 Tromsø, Norway.
  • Rylander C; Department of Community Medicine, University of Tromsø - The Arctic University of Norway, 9037 Tromsø, Norway.
  • Manjavidze T; Department of Community Medicine, University of Tromsø - The Arctic University of Norway, 9037 Tromsø, Norway.
  • Gamkrelidze A; National Center for Disease Control and Public Health Georgia, 0198 Tbilisi, Georgia.
  • Baliashvili D; University of Georgia, 0171 Tbilisi, Georgia.
  • Anda EE; The Task Force for Global Health, 0198 Tbilisi, Georgia.
J Infect Dis ; 2024 Mar 01.
Article en En | MEDLINE | ID: mdl-38427715
ABSTRACT

OBJECTIVE:

To evaluate the impact of hepatitis C virus (HCV) infection and treatment status on COVID-19-related hospitalizations in Georgia.

METHODS:

We analyzed 2020-2021 Georgian health-registry data for COVID-19-positive individuals and categorized by HCV infection and treatment status. Logistic regression was used to assess the strengths of the associations.

RESULTS:

Treated HCV individuals had lower odds of COVID-19-related hospitalization compared to anti-HCV-negatives, while untreated HCV-viremic and anti-HCV-positive non-viremic individuals had higher odds.

CONCLUSIONS:

HCV treatment prior to COVID-19 infection was associated with lower odds of COVID-19-related hospitalization, highlighting the benefits of HCV management in the context of the pandemic.
Palabras clave

Texto completo: 1 Banco de datos: MEDLINE Idioma: En Año: 2024 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Idioma: En Año: 2024 Tipo del documento: Article